Search research articles
Contact Us
Filters
Showing results (211-220 of 402) with videos related to
Page
of 41
Sort By:
Journal of Oncology Practice
|
January 16, 2014
Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual
Diane St Germain, Andrea M Denicoff, Eileen P Dimond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2015
Anxiety and health-related quality of life among patients with low-tumor burden non-Hodgkin lymphoma randomly assigned to two different rituximab dosing regimens: results from ECOG trial E4402 (RESORT)
Lynne I Wagner, Fengmin Zhao, Fangxin Hong, et al.
British Journal of Haematology
|
June 23, 2016
Natural history of amyloidosis isolated to fat and bone marrow aspirate
Rajshekhar Chakraborty, Morie A Gertz, Angela Dispenzieri, et al.
JAMA
|
December 29, 2016
Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial
Andrew L Himelstein, Jared C Foster, James L Khatcheressian, et al.
British Journal of Haematology
|
February 18, 2026
Systemic Xanthogranuloma or Erdheim-Chester disease: A systematic review re-examining the classification challenge
Vyshnavi Rallapalle, Sailesh I S Kumar, Brinda Shukla, et al.
JAMA Network Open
|
March 28, 2025
Practical Anemia Bundle and Hemoglobin Recovery in Critical Illness: A Randomized Clinical Trial
Matthew A Warner, Matthew L Johnson, Andrew C Hanson, et al.
Leukemia
|
April 15, 2018
Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset
Gaurav Goyal, Adam C Bartley, Shealeigh Funni, et al.
American Journal of Hematology
|
August 12, 2014
Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias
Taxiarchis V Kourelis, Shaji K Kumar, Ronald S Go, et al.
Mayo Clinic Proceedings
|
February 7, 2021
Coagulation Abnormalities in Light Chain Amyloidosis
Nadine Abdallah, Eli Muchtar, Angela Dispenzieri, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 31, 2016
Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies
Larissa S Higgins, Ronald S Go, David Dingli, et al.
Page
of 41
Search research articles
Search
Showing results (211-220 of 402) with videos related to
Sort By:
Page
of 41
Journal of Oncology Practice
|
January 16, 2014
Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual
Diane St Germain, Andrea M Denicoff, Eileen P Dimond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2015
Anxiety and health-related quality of life among patients with low-tumor burden non-Hodgkin lymphoma randomly assigned to two different rituximab dosing regimens: results from ECOG trial E4402 (RESORT)
Lynne I Wagner, Fengmin Zhao, Fangxin Hong, et al.
British Journal of Haematology
|
June 23, 2016
Natural history of amyloidosis isolated to fat and bone marrow aspirate
Rajshekhar Chakraborty, Morie A Gertz, Angela Dispenzieri, et al.
JAMA
|
December 29, 2016
Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial
Andrew L Himelstein, Jared C Foster, James L Khatcheressian, et al.
British Journal of Haematology
|
February 18, 2026
Systemic Xanthogranuloma or Erdheim-Chester disease: A systematic review re-examining the classification challenge
Vyshnavi Rallapalle, Sailesh I S Kumar, Brinda Shukla, et al.
JAMA Network Open
|
March 28, 2025
Practical Anemia Bundle and Hemoglobin Recovery in Critical Illness: A Randomized Clinical Trial
Matthew A Warner, Matthew L Johnson, Andrew C Hanson, et al.
Leukemia
|
April 15, 2018
Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset
Gaurav Goyal, Adam C Bartley, Shealeigh Funni, et al.
American Journal of Hematology
|
August 12, 2014
Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias
Taxiarchis V Kourelis, Shaji K Kumar, Ronald S Go, et al.
Mayo Clinic Proceedings
|
February 7, 2021
Coagulation Abnormalities in Light Chain Amyloidosis
Nadine Abdallah, Eli Muchtar, Angela Dispenzieri, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 31, 2016
Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies
Larissa S Higgins, Ronald S Go, David Dingli, et al.
Page
of 41